Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	4,870	`("Malignant Female Reproductive System Neoplasm"[tiab] OR "Gynecologic Cancer"[tiab] OR "Malignant Gynecologic Tumor"[tiab] OR "Malignant Gynecologic Neoplasm"[tiab] OR "Female Reproductive Organ Cancer"[tiab] OR "Female Reproductive System Cancer"[tiab] OR "Female reprod. system cancer, NOS"[tiab] OR "Cancer of Female Reproductive System"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	1,820	`("Malignant Female Reproductive System Neoplasm"[tiab] OR "Gynecologic Cancer"[tiab] OR "Malignant Gynecologic Tumor"[tiab] OR "Malignant Gynecologic Neoplasm"[tiab] OR "Female Reproductive Organ Cancer"[tiab] OR "Female Reproductive System Cancer"[tiab] OR "Female reprod. system cancer, NOS"[tiab] OR "Cancer of Female Reproductive System"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	387	`("Malignant Female Reproductive System Neoplasm"[tiab] OR "Gynecologic Cancer"[tiab] OR "Malignant Gynecologic Tumor"[tiab] OR "Malignant Gynecologic Neoplasm"[tiab] OR "Female Reproductive Organ Cancer"[tiab] OR "Female Reproductive System Cancer"[tiab] OR "Female reprod. system cancer, NOS"[tiab] OR "Cancer of Female Reproductive System"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (320)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 301–320 of 320 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR.
· Nat Commun · 2025 · PMID 40169546 · validated civic_curation pubmed
Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro.
· PLoS One · 2014 · PMID 24927325 · validated civic_curation pubmed
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
· Mol Cancer Ther · 2006 · PMID 17088436 · validated civic_curation pubmed
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.